1. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target
   Masaaki Kuda et al, 2016, Tumor Biology CrossRef
2. Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
   Camille Jacques et al, 2016, Oncotarget CrossRef
3. A Significant Question in Cancer Risk and Therapy: Are Antibiotics Positive or Negative Effectors? Current Answers and Possible Alternatives
   Steffanie S. Amadei et al, 2020, Antibiotics CrossRef
4. The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications
   Christian Bailly, 2022, European Journal of Pharmacology CrossRef
5. FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD‐L1 Expression and Cell Proliferation
   Hamadi Madhi et al, 2022, Advanced Science CrossRef
6. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma
   Lizhu Jiang et al, 2015, Journal of Cancer Research and Clinical Oncology CrossRef
7. EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma
   Muhammad Yasir et al, 2023, International Journal of Molecular Sciences CrossRef
8. Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing Yap1/FOXM1 pathway-dependent lipid synthesis
   Peiguang Zhang et al, 2024, Acta Biochimica et Biophysica Sinica CrossRef
9. EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
   Florencia Cidre-Aranaz et al, 2015, Frontiers in Oncology CrossRef
10. Role of FOXM1 in vascular smooth muscle cell survival and neointima formation following vascular injury
    Sarah Franco et al, 2020, Heliyon CrossRef
11. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy
    Heinrich Kovar, 2014, Expert Opinion on Therapeutic Targets CrossRef
12. Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells
    G-A Franzetti et al, 2017, Oncogene CrossRef
13. Targeted Therapy for EWS-FLI1 in Ewing Sarcoma
    Helong Gong et al, 2023, Cancers CrossRef
14. FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways
    Fergal C. Kelleher et al, 2106, Oncotarget CrossRef
15. Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma
    Dana L. Casey et al, 2019, Frontiers in Oncology CrossRef